Philip Joseph

Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study

Salim Yusuf, Philip Joseph, Sumathy Rangarajan et al. · The Lancet · 2019 · 2K citations · Full text

Public Health, Chronic Disease Prevention, Preventive Medicine +17

Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study

Gilles R. Dagenais, Darryl P. Leong, Sumathy Rangarajan et al. · The Lancet · 2019 · 654 citations

Veterinary Medicine, Geriatric Medicine, Internal Medicine +15

Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study

Annika Rosengren, Andrew Smyth, Sumathy Rangarajan et al. · The Lancet Global Health · 2019 · 644 citations · Full text

Public Health, Population Health Sciences, Epidemiology +16

Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study

Marjan Walli-Attaei, Philip Joseph, Annika Rosengren et al. · The Lancet · 2020 · 335 citations

Public Health, Cardiology, Health Sciences +17

Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial

P.J. Devereaux, Emmanuelle Duceppe, Gordon Guyatt et al. · The Lancet · 2018 · 325 citations · Full text

Medicine, Cardiology, Surgery +13